Financial statements Aristo Pharma
Cash flow statement of Aristo Pharma
Company age:
Age:
19 y. 11 m. 2 d.
Share capital:
Share capital:
50 000 PLN
Cash inflows of ARISTO PHARMA
|
Year
|
2018
|
2019
|
2020
|
|---|---|---|---|
| Net cash from operating expenses | 7 510 563,79 | 6 886 877,81 | 1 913 128,33 |
| Net cash flow from investing activities | -199 727,31 | -392 615,91 | -151 461,75 |
| Net cash flow from financial activities | -6 231 623,62 | -7 226 153,22 | -832 935,35 |
| Total net cash flow | 1 079 212,86 | -731 891,32 | 928 731,23 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.